Global Cardiac Safety Monitoring Service market cagr 10.4%

Cardiac Safety Monitoring Service Market

Cardiac Safety Monitoring Service Market Scope: Industry Analysis, Market Size, Growth, Trends Till

Request Sample Report

Cardiac Safety Monitoring Service Market Size and Growth

The global Cardiac Safety Monitoring Service market is projected to reach a value of $1.2 billion by 2025, with a CAGR of 7.5%. The increasing prevalence of cardiovascular diseases, technological advances in monitoring devices, and rising demand for personalized medicine are driving market growth. Key players include IQVIA, LabCorp, and Biotrial.

Companies Covered (Covid 19 Impact

Covered)

◍ BioTelemetry, Inc (Philips)

◍ Clario

◍ Celerion, Inc

◍ Certara L.P.

◍ Medpace

◍ Laboratory Corporation of America

Holdings

◍ Banook Group

◍ Richmond Pharmacology

◍ PhysioStim

◍ IQVIA

◍ SGS SA

◍ MicroConstants

◍ Shanghai Medicilon Inc

◍ Pharmaron Beijing Co.,Ltd.

◍ JOINN Laboratories

◍ Spaulding Clinical Research, LLC

◍ Corelab Partners

The Cardiac Safety Monitoring Service Market is highly competitive with companies like BioTelemetry, Inc (Philips), Clario, Celerion, Inc, Certara L.P., Medpace, and others offering services to pharmaceutical companies for clinical trials. These companies provide ECG monitoring, Holter monitoring, and safety assessments to ensure the cardiac safety of new drugs.

- BioTelemetry, Inc (Philips) reported sales revenue in 2020 of $487 million.

- Celerion, Inc reported sales revenue in 2020 of $100 million.

- Medpace reported sales revenue in 2020 of $860 million.

- Laboratory Corporation of America Holdings reported sales revenue in 2020 of $11.8 billion.

Request Sample Report

Market Segmentation

By Application

◍ Pharmaceutical and Biopharmaceuticals Companies

◍ Contract Research Organization(CRO)

◍ Others Request

By Product

◍ Integrated Services

◍ Standalone Services